Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

MLTXMLTX
Showing 8 of 15 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in MoonLake Immunotherapeutics Class A

PRICE T ROWE ASSOCIATES INC /MD/ holds 1M shares of MLTX (MoonLake Immunotherapeutics Class A), worth $20,279 as of 2026-Q2. The position was decreased (-19.6% shares). MLTX represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$20,279

Current Shares

1M

Total Value Change

-$150.2M

Total Shares Change

-1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1M
-19.6%
$20,2790.0%$19.47
0
2026-Q1
Increased
1.3M
+34.9%
$24.1M0.0%$17.69
37
2025-Q4
Increased
959,553
+16.6%
$12.6M0.0%$13.21
32
2025-Q3
Decreased
822,957
-68.5%
$5.9M0.0%$6.24
0
2025-Q2
Decreased
2.6M
-12.1%
$123.3M0.0%$47.52
0
2025-Q1
Decreased
3M
-11.1%
$116.2M0.0%$39.86
0
2024-Q4
Increased
3.3M
+12.2%
$181.1M0.0%$53.02
34
2024-Q3
Increased
3M
+16.4%
$150.3M0.0%$49.40
35

Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used